nodes	percent_of_prediction	percent_of_DWPC	metapath
Potassium Canrenoate—Prednisone—psoriatic arthritis	0.295	0.506	CrCtD
Potassium Canrenoate—Prednisolone—psoriatic arthritis	0.288	0.494	CrCtD
Potassium Canrenoate—Medroxyprogesterone Acetate—Methylprednisolone—psoriatic arthritis	0.0133	0.033	CrCrCtD
Potassium Canrenoate—Hydrocortamate—Methylprednisolone—psoriatic arthritis	0.012	0.0298	CrCrCtD
Potassium Canrenoate—Cortisone acetate—Methylprednisolone—psoriatic arthritis	0.0116	0.0289	CrCrCtD
Potassium Canrenoate—Hydrocortamate—Prednisone—psoriatic arthritis	0.0109	0.0272	CrCrCtD
Potassium Canrenoate—Hydrocortamate—Prednisolone—psoriatic arthritis	0.0107	0.0265	CrCrCtD
Potassium Canrenoate—Cortisone acetate—Prednisone—psoriatic arthritis	0.0106	0.0263	CrCrCtD
Potassium Canrenoate—Cortisone acetate—Prednisolone—psoriatic arthritis	0.0104	0.0257	CrCrCtD
Potassium Canrenoate—Fluoxymesterone—Betamethasone—psoriatic arthritis	0.0102	0.0253	CrCrCtD
Potassium Canrenoate—Fluoxymesterone—Dexamethasone—psoriatic arthritis	0.0102	0.0253	CrCrCtD
Potassium Canrenoate—Prednisone—Methylprednisolone—psoriatic arthritis	0.0101	0.0251	CrCrCtD
Potassium Canrenoate—Fludrocortisone—Methylprednisolone—psoriatic arthritis	0.0101	0.0251	CrCrCtD
Potassium Canrenoate—Fluoxymesterone—Triamcinolone—psoriatic arthritis	0.00997	0.0247	CrCrCtD
Potassium Canrenoate—Fludrocortisone—Betamethasone—psoriatic arthritis	0.00994	0.0247	CrCrCtD
Potassium Canrenoate—Fludrocortisone—Dexamethasone—psoriatic arthritis	0.00994	0.0247	CrCrCtD
Potassium Canrenoate—Prednisone—Dexamethasone—psoriatic arthritis	0.00994	0.0247	CrCrCtD
Potassium Canrenoate—Prednisone—Betamethasone—psoriatic arthritis	0.00994	0.0247	CrCrCtD
Potassium Canrenoate—Fludrocortisone—Triamcinolone—psoriatic arthritis	0.00971	0.0241	CrCrCtD
Potassium Canrenoate—Prednisone—Triamcinolone—psoriatic arthritis	0.00971	0.0241	CrCrCtD
Potassium Canrenoate—Loteprednol—Methylprednisolone—psoriatic arthritis	0.00938	0.0233	CrCrCtD
Potassium Canrenoate—Fluoxymesterone—Prednisolone—psoriatic arthritis	0.00923	0.0229	CrCrCtD
Potassium Canrenoate—Loteprednol—Betamethasone—psoriatic arthritis	0.00923	0.0229	CrCrCtD
Potassium Canrenoate—Loteprednol—Dexamethasone—psoriatic arthritis	0.00923	0.0229	CrCrCtD
Potassium Canrenoate—Fludrocortisone—Prednisone—psoriatic arthritis	0.00921	0.0229	CrCrCtD
Potassium Canrenoate—Loteprednol—Triamcinolone—psoriatic arthritis	0.00902	0.0224	CrCrCtD
Potassium Canrenoate—Fludrocortisone—Prednisolone—psoriatic arthritis	0.00899	0.0223	CrCrCtD
Potassium Canrenoate—Prednisone—Prednisolone—psoriatic arthritis	0.00899	0.0223	CrCrCtD
Potassium Canrenoate—Progesterone—Prednisolone—psoriatic arthritis	0.00899	0.0223	CrCrCtD
Potassium Canrenoate—Methyltestosterone—Prednisone—psoriatic arthritis	0.00898	0.0223	CrCrCtD
Potassium Canrenoate—Methyltestosterone—Prednisolone—psoriatic arthritis	0.00877	0.0218	CrCrCtD
Potassium Canrenoate—Prednisolone—Methylprednisolone—psoriatic arthritis	0.00858	0.0213	CrCrCtD
Potassium Canrenoate—Loteprednol—Prednisone—psoriatic arthritis	0.00856	0.0212	CrCrCtD
Potassium Canrenoate—Prednisolone—Dexamethasone—psoriatic arthritis	0.00844	0.021	CrCrCtD
Potassium Canrenoate—Prednisolone—Betamethasone—psoriatic arthritis	0.00844	0.021	CrCrCtD
Potassium Canrenoate—Loteprednol—Prednisolone—psoriatic arthritis	0.00835	0.0207	CrCrCtD
Potassium Canrenoate—Prednisolone—Triamcinolone—psoriatic arthritis	0.00825	0.0205	CrCrCtD
Potassium Canrenoate—Hydrocortisone—Methylprednisolone—psoriatic arthritis	0.00823	0.0204	CrCrCtD
Potassium Canrenoate—Hydrocortisone—Betamethasone—psoriatic arthritis	0.0081	0.0201	CrCrCtD
Potassium Canrenoate—Hydrocortisone—Dexamethasone—psoriatic arthritis	0.0081	0.0201	CrCrCtD
Potassium Canrenoate—Hydrocortisone—Triamcinolone—psoriatic arthritis	0.00792	0.0197	CrCrCtD
Potassium Canrenoate—Prednisolone—Prednisone—psoriatic arthritis	0.00783	0.0194	CrCrCtD
Potassium Canrenoate—Testosterone—Prednisolone—psoriatic arthritis	0.00781	0.0194	CrCrCtD
Potassium Canrenoate—Hydrocortisone—Prednisone—psoriatic arthritis	0.00751	0.0187	CrCrCtD
Potassium Canrenoate—Hydrocortisone—Prednisolone—psoriatic arthritis	0.00733	0.0182	CrCrCtD
Potassium Canrenoate—Loose stools—Auranofin—psoriatic arthritis	0.00138	0.0957	CcSEcCtD
Potassium Canrenoate—Gastrointestinal ulcer haemorrhage—Methotrexate—psoriatic arthritis	0.00077	0.0535	CcSEcCtD
Potassium Canrenoate—Paresthesia of limbs—Methotrexate—psoriatic arthritis	0.00077	0.0535	CcSEcCtD
Potassium Canrenoate—Flatulence—Auranofin—psoriatic arthritis	0.000328	0.0228	CcSEcCtD
Potassium Canrenoate—Ulcer—Triamcinolone—psoriatic arthritis	0.000236	0.0164	CcSEcCtD
Potassium Canrenoate—Extravasation—Dexamethasone—psoriatic arthritis	0.000232	0.0162	CcSEcCtD
Potassium Canrenoate—Extravasation—Betamethasone—psoriatic arthritis	0.000232	0.0162	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.000222	0.0155	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Auranofin—psoriatic arthritis	0.000215	0.015	CcSEcCtD
Potassium Canrenoate—Ulcer—Betamethasone—psoriatic arthritis	0.000214	0.0149	CcSEcCtD
Potassium Canrenoate—Ulcer—Dexamethasone—psoriatic arthritis	0.000214	0.0149	CcSEcCtD
Potassium Canrenoate—Ulcer—Prednisone—psoriatic arthritis	0.000187	0.013	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Auranofin—psoriatic arthritis	0.000186	0.0129	CcSEcCtD
Potassium Canrenoate—Vomiting—Auranofin—psoriatic arthritis	0.000173	0.012	CcSEcCtD
Potassium Canrenoate—Rash—Auranofin—psoriatic arthritis	0.000171	0.0119	CcSEcCtD
Potassium Canrenoate—Dermatitis—Auranofin—psoriatic arthritis	0.000171	0.0119	CcSEcCtD
Potassium Canrenoate—Extravasation—Methotrexate—psoriatic arthritis	0.000169	0.0118	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Prednisolone—psoriatic arthritis	0.000168	0.0117	CcSEcCtD
Potassium Canrenoate—Nausea—Auranofin—psoriatic arthritis	0.000162	0.0112	CcSEcCtD
Potassium Canrenoate—Ulcer—Methotrexate—psoriatic arthritis	0.000156	0.0109	CcSEcCtD
Potassium Canrenoate—Dysarthria—Methotrexate—psoriatic arthritis	0.000156	0.0109	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Triamcinolone—psoriatic arthritis	0.000154	0.0107	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Methylprednisolone—psoriatic arthritis	0.000154	0.0107	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Dexamethasone—psoriatic arthritis	0.00014	0.00973	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Betamethasone—psoriatic arthritis	0.00014	0.00973	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Prednisolone—psoriatic arthritis	0.000123	0.00853	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Prednisolone—psoriatic arthritis	0.000122	0.00849	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Prednisone—psoriatic arthritis	0.000122	0.00848	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Triamcinolone—psoriatic arthritis	0.000113	0.00785	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.000113	0.00783	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Triamcinolone—psoriatic arthritis	0.000112	0.00781	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.000112	0.00779	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Prednisolone—psoriatic arthritis	0.000109	0.00758	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Dexamethasone—psoriatic arthritis	0.000102	0.00712	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Betamethasone—psoriatic arthritis	0.000102	0.00712	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Betamethasone—psoriatic arthritis	0.000102	0.00708	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Dexamethasone—psoriatic arthritis	0.000102	0.00708	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Triamcinolone—psoriatic arthritis	0.0001	0.00697	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Methylprednisolone—psoriatic arthritis	0.0001	0.00696	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Dexamethasone—psoriatic arthritis	9.1e-05	0.00633	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Betamethasone—psoriatic arthritis	9.1e-05	0.00633	CcSEcCtD
Potassium Canrenoate—Discomfort—Prednisolone—psoriatic arthritis	8.94e-05	0.00622	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Prednisone—psoriatic arthritis	8.92e-05	0.0062	CcSEcCtD
Potassium Canrenoate—Abdominal discomfort—Methotrexate—psoriatic arthritis	8.88e-05	0.00617	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Prednisone—psoriatic arthritis	8.87e-05	0.00617	CcSEcCtD
Potassium Canrenoate—Discomfort—Triamcinolone—psoriatic arthritis	8.22e-05	0.00572	CcSEcCtD
Potassium Canrenoate—Discomfort—Methylprednisolone—psoriatic arthritis	8.2e-05	0.0057	CcSEcCtD
Potassium Canrenoate—Confusional state—Methylprednisolone—psoriatic arthritis	8.02e-05	0.00558	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Prednisone—psoriatic arthritis	7.92e-05	0.00551	CcSEcCtD
Potassium Canrenoate—Infection—Triamcinolone—psoriatic arthritis	7.92e-05	0.00551	CcSEcCtD
Potassium Canrenoate—Infection—Methylprednisolone—psoriatic arthritis	7.91e-05	0.0055	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Prednisolone—psoriatic arthritis	7.79e-05	0.00541	CcSEcCtD
Potassium Canrenoate—Discomfort—Dexamethasone—psoriatic arthritis	7.46e-05	0.00519	CcSEcCtD
Potassium Canrenoate—Discomfort—Betamethasone—psoriatic arthritis	7.46e-05	0.00519	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Methotrexate—psoriatic arthritis	7.45e-05	0.00518	CcSEcCtD
Potassium Canrenoate—Hypotension—Methylprednisolone—psoriatic arthritis	7.44e-05	0.00517	CcSEcCtD
Potassium Canrenoate—Pain—Prednisolone—psoriatic arthritis	7.42e-05	0.00516	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Methotrexate—psoriatic arthritis	7.41e-05	0.00515	CcSEcCtD
Potassium Canrenoate—Infection—Betamethasone—psoriatic arthritis	7.19e-05	0.005	CcSEcCtD
Potassium Canrenoate—Infection—Dexamethasone—psoriatic arthritis	7.19e-05	0.005	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Triamcinolone—psoriatic arthritis	7.16e-05	0.00498	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Prednisolone—psoriatic arthritis	7.15e-05	0.00497	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Methylprednisolone—psoriatic arthritis	7.15e-05	0.00497	CcSEcCtD
Potassium Canrenoate—Pain—Triamcinolone—psoriatic arthritis	6.82e-05	0.00474	CcSEcCtD
Potassium Canrenoate—Hypotension—Betamethasone—psoriatic arthritis	6.76e-05	0.0047	CcSEcCtD
Potassium Canrenoate—Hypotension—Dexamethasone—psoriatic arthritis	6.76e-05	0.0047	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Triamcinolone—psoriatic arthritis	6.57e-05	0.00457	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Methylprednisolone—psoriatic arthritis	6.56e-05	0.00456	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	6.51e-05	0.00452	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Dexamethasone—psoriatic arthritis	6.5e-05	0.00452	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Betamethasone—psoriatic arthritis	6.5e-05	0.00452	CcSEcCtD
Potassium Canrenoate—Discomfort—Prednisone—psoriatic arthritis	6.5e-05	0.00452	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Triamcinolone—psoriatic arthritis	6.3e-05	0.00438	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Methylprednisolone—psoriatic arthritis	6.29e-05	0.00437	CcSEcCtD
Potassium Canrenoate—Infection—Prednisone—psoriatic arthritis	6.26e-05	0.00435	CcSEcCtD
Potassium Canrenoate—Pain—Betamethasone—psoriatic arthritis	6.19e-05	0.0043	CcSEcCtD
Potassium Canrenoate—Pain—Dexamethasone—psoriatic arthritis	6.19e-05	0.0043	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Betamethasone—psoriatic arthritis	5.96e-05	0.00415	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Dexamethasone—psoriatic arthritis	5.96e-05	0.00415	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Betamethasone—psoriatic arthritis	5.92e-05	0.00411	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	5.92e-05	0.00411	CcSEcCtD
Potassium Canrenoate—Asthenia—Triamcinolone—psoriatic arthritis	5.72e-05	0.00398	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Betamethasone—psoriatic arthritis	5.72e-05	0.00398	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Dexamethasone—psoriatic arthritis	5.72e-05	0.00398	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Dexamethasone—psoriatic arthritis	5.72e-05	0.00398	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Betamethasone—psoriatic arthritis	5.72e-05	0.00398	CcSEcCtD
Potassium Canrenoate—Asthenia—Methylprednisolone—psoriatic arthritis	5.71e-05	0.00397	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Prednisone—psoriatic arthritis	5.66e-05	0.00393	CcSEcCtD
Potassium Canrenoate—Rash—Prednisolone—psoriatic arthritis	5.47e-05	0.0038	CcSEcCtD
Potassium Canrenoate—Dermatitis—Prednisolone—psoriatic arthritis	5.46e-05	0.0038	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Methylprednisolone—psoriatic arthritis	5.44e-05	0.00379	CcSEcCtD
Potassium Canrenoate—Discomfort—Methotrexate—psoriatic arthritis	5.43e-05	0.00377	CcSEcCtD
Potassium Canrenoate—Confusional state—Methotrexate—psoriatic arthritis	5.31e-05	0.00369	CcSEcCtD
Potassium Canrenoate—Infection—Methotrexate—psoriatic arthritis	5.23e-05	0.00364	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Prednisone—psoriatic arthritis	5.19e-05	0.00361	CcSEcCtD
Potassium Canrenoate—Asthenia—Dexamethasone—psoriatic arthritis	5.19e-05	0.00361	CcSEcCtD
Potassium Canrenoate—Asthenia—Betamethasone—psoriatic arthritis	5.19e-05	0.00361	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Prednisone—psoriatic arthritis	5.15e-05	0.00358	CcSEcCtD
Potassium Canrenoate—Nausea—Prednisolone—psoriatic arthritis	5.15e-05	0.00358	CcSEcCtD
Potassium Canrenoate—Vomiting—Triamcinolone—psoriatic arthritis	5.07e-05	0.00353	CcSEcCtD
Potassium Canrenoate—Vomiting—Methylprednisolone—psoriatic arthritis	5.06e-05	0.00352	CcSEcCtD
Potassium Canrenoate—Rash—Triamcinolone—psoriatic arthritis	5.03e-05	0.0035	CcSEcCtD
Potassium Canrenoate—Dermatitis—Triamcinolone—psoriatic arthritis	5.02e-05	0.00349	CcSEcCtD
Potassium Canrenoate—Rash—Methylprednisolone—psoriatic arthritis	5.02e-05	0.00349	CcSEcCtD
Potassium Canrenoate—Dermatitis—Methylprednisolone—psoriatic arthritis	5.01e-05	0.00349	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Prednisone—psoriatic arthritis	4.98e-05	0.00346	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Prednisone—psoriatic arthritis	4.98e-05	0.00346	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Dexamethasone—psoriatic arthritis	4.95e-05	0.00344	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Betamethasone—psoriatic arthritis	4.95e-05	0.00344	CcSEcCtD
Potassium Canrenoate—Hypotension—Methotrexate—psoriatic arthritis	4.92e-05	0.00342	CcSEcCtD
Potassium Canrenoate—Nausea—Triamcinolone—psoriatic arthritis	4.74e-05	0.00329	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Methotrexate—psoriatic arthritis	4.73e-05	0.00329	CcSEcCtD
Potassium Canrenoate—Nausea—Methylprednisolone—psoriatic arthritis	4.73e-05	0.00329	CcSEcCtD
Potassium Canrenoate—Vomiting—Betamethasone—psoriatic arthritis	4.6e-05	0.0032	CcSEcCtD
Potassium Canrenoate—Vomiting—Dexamethasone—psoriatic arthritis	4.6e-05	0.0032	CcSEcCtD
Potassium Canrenoate—Rash—Betamethasone—psoriatic arthritis	4.56e-05	0.00317	CcSEcCtD
Potassium Canrenoate—Rash—Dexamethasone—psoriatic arthritis	4.56e-05	0.00317	CcSEcCtD
Potassium Canrenoate—Dermatitis—Dexamethasone—psoriatic arthritis	4.56e-05	0.00317	CcSEcCtD
Potassium Canrenoate—Dermatitis—Betamethasone—psoriatic arthritis	4.56e-05	0.00317	CcSEcCtD
Potassium Canrenoate—Asthenia—Prednisone—psoriatic arthritis	4.52e-05	0.00314	CcSEcCtD
Potassium Canrenoate—Pain—Methotrexate—psoriatic arthritis	4.5e-05	0.00313	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Methotrexate—psoriatic arthritis	4.34e-05	0.00302	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Prednisone—psoriatic arthritis	4.31e-05	0.003	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Methotrexate—psoriatic arthritis	4.31e-05	0.00299	CcSEcCtD
Potassium Canrenoate—Nausea—Dexamethasone—psoriatic arthritis	4.3e-05	0.00299	CcSEcCtD
Potassium Canrenoate—Nausea—Betamethasone—psoriatic arthritis	4.3e-05	0.00299	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Methotrexate—psoriatic arthritis	4.16e-05	0.00289	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Methotrexate—psoriatic arthritis	4.16e-05	0.00289	CcSEcCtD
Potassium Canrenoate—Vomiting—Prednisone—psoriatic arthritis	4.01e-05	0.00279	CcSEcCtD
Potassium Canrenoate—Rash—Prednisone—psoriatic arthritis	3.97e-05	0.00276	CcSEcCtD
Potassium Canrenoate—Dermatitis—Prednisone—psoriatic arthritis	3.97e-05	0.00276	CcSEcCtD
Potassium Canrenoate—Asthenia—Methotrexate—psoriatic arthritis	3.78e-05	0.00263	CcSEcCtD
Potassium Canrenoate—Nausea—Prednisone—psoriatic arthritis	3.74e-05	0.0026	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Methotrexate—psoriatic arthritis	3.6e-05	0.00251	CcSEcCtD
Potassium Canrenoate—Vomiting—Methotrexate—psoriatic arthritis	3.35e-05	0.00233	CcSEcCtD
Potassium Canrenoate—Rash—Methotrexate—psoriatic arthritis	3.32e-05	0.00231	CcSEcCtD
Potassium Canrenoate—Dermatitis—Methotrexate—psoriatic arthritis	3.32e-05	0.00231	CcSEcCtD
Potassium Canrenoate—Nausea—Methotrexate—psoriatic arthritis	3.13e-05	0.00218	CcSEcCtD
